Second-line treatment in EGFR-unselected patients: is it time to close one arm of this river’s DELTA?

Benzer Materyaller

• Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond
  Yazar:: Karachaliou, Niki, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study
  Yazar:: Karachaliou, Niki, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A new proteomic test could guide treatment decision in second-line therapy for patients with EGFR unselected non-small cell lung cancer?
  Yazar:: Mazzoni, Francesca, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Wetlands in the river delta plains: evolution, values and functions during the Roman times. The coastal landscape close to the Garigliano river mouth
  Yazar:: Ferrari, Kevin, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
  Yazar:: Felip, Enriqueta, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)